Triple

T1444629
Position Surface form Disambiguated ID Type / Status
Subject Cancer Res E31149 entity
Predicate hasAbbreviation P43 FINISHED
Object Cancer Res E31149 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cancer Res | Statement: [Cancer Res, hasAbbreviation, Cancer Res]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Cancer Res
Context triple: [Cancer Res, hasAbbreviation, Cancer Res]
  • A. Cancer Res chosen
    Cancer Res is a leading peer-reviewed scientific journal that publishes research on the molecular and cellular biology, genetics, and treatment of cancer.
  • B. Molecular Cancer Therapeutics
    Molecular Cancer Therapeutics is a peer-reviewed scientific journal focusing on the discovery, development, and clinical evaluation of novel cancer therapeutics.
  • C. Cancer Discovery
    Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
  • D. Molecular Cancer Research
    Molecular Cancer Research is a peer-reviewed scientific journal focusing on the molecular and cellular biology of cancer.
  • E. AACR journal portfolio
    The AACR journal portfolio is a collection of peer-reviewed scientific journals published by the American Association for Cancer Research that cover a broad range of topics in cancer biology, prevention, diagnosis, and treatment.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a4991633388190a4d61b5a98aa407a completed March 1, 2026, 7:52 p.m.
NER Named-entity recognition batch_69a4c5353fdc819090481cbdd1162929 completed March 1, 2026, 11:01 p.m.
NED1 Entity disambiguation (via context triple) batch_69ad08c046b08190a448ba2549dc5e00 completed March 8, 2026, 5:27 a.m.
Created at: March 1, 2026, 8 p.m.